Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_assertion type Assertion NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_head.
- NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_assertion description "[FTY720 suppresses the disease activity of multiple sclerosis (MS) chiefly by inhibiting S1P-dependent egress of autoreactive T lymphocytes from secondary lymphoid organs, and possibly by exerting anti-inflammatory and neuroprotective effects directly on brain cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_provenance.
- NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_assertion evidence source_evidence_literature NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_provenance.
- NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_assertion SIO_000772 21519925 NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_provenance.
- NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_assertion wasDerivedFrom befree-20140225 NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_provenance.
- NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_assertion wasGeneratedBy ECO_0000203 NP718034.RA-FGtDhGUlaM_1CrPh-nw2gztjLRC_NXb0NgLaIpz5fE130_provenance.